Transcat (NASDAQ:TRNS) Raised to Strong-Buy at Zacks Research

Transcat (NASDAQ:TRNS) was upgraded by equities researchers at Zacks Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Thursday, Zacks reports.

Other equities research analysts have also issued reports about the company. CJS Securities began coverage on Transcat in a research report on Tuesday, October 27th. They issued an “outperform” rating and a $115.00 price objective on the stock. Northland Securities upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price for the company in a report on Wednesday, October 21st. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a research note on Tuesday, August 25th. Finally, Oppenheimer upgraded shares of Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 price target on the stock in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $108.33.

Transcat Trading Up 1.1%

Shares of NASDAQ TRNS traded up $1.13 during trading hours on Thursday, hitting $101.51. The company’s stock had a trading volume of 169,759 shares, compared to its average volume of 135,380. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.11 and a current ratio of 2.49. The stock has a market cap of $953.18 million, a price-to-earnings ratio of 211.48 and a beta of 0.61. Transcat has a 12 month low of $50.23 and a 12 month high of $110.47. The business has a 50-day simple moving average of $86.94 and a 200-day simple moving average of $82.43.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.19. The company had revenue of $97.09 million for the quarter, compared to the consensus estimate of $92.46 million. Transcat had a return on equity of 5.56% and a net margin of 0.99%. On average, analysts anticipate that Transcat will post 2.06 earnings per share for the current fiscal year.

Insider Transactions at Transcat

In related news, CEO Jaime A. Irick acquired 2,275 shares of the stock in a transaction on Thursday, November 5th. The stock was acquired at an average cost of $101.26 per share, for a total transaction of $230,366.50. Following the completion of the acquisition, the chief executive officer directly owned 2,275 shares of the company’s stock, valued at approximately $230,366.50. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in TRNS. Russell Investments Group Ltd. lifted its stake in shares of Transcat by 41.8% in the 3rd quarter. Russell Investments Group Ltd. now owns 24,929 shares of the scientific and technical instruments company’s stock valued at $2,204,000 after purchasing an additional 7,348 shares during the period. R Squared Ltd purchased a new stake in Transcat in the third quarter worth $274,000. Riverbridge Partners LLC grew its stake in Transcat by 8.4% in the third quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock worth $19,404,000 after purchasing an additional 17,063 shares during the period. Summit Creek Advisors LLC raised its holdings in Transcat by 23.8% in the third quarter. Summit Creek Advisors LLC now owns 58,135 shares of the scientific and technical instruments company’s stock worth $5,140,000 after purchasing an additional 11,165 shares in the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Transcat in the third quarter worth $221,000. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat News Roundup

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
• Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
• Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
• Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
• Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target

About Transcat

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.